4008 — Sumitomo Seika Chemicals Co Balance Sheet
0.000.00%
- ¥63bn
- ¥56bn
- ¥143bn
- 78
- 94
- 53
- 89
Annual balance sheet for Sumitomo Seika Chemicals Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 15,366 | 25,657 | 29,248 | 23,553 | 21,662 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23,200 | 24,208 | 26,734 | 28,571 | 31,874 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 59,440 | 68,164 | 81,312 | 85,195 | 86,991 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 36,576 | 34,775 | 34,308 | 34,528 | 39,867 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 100,261 | 107,834 | 121,274 | 126,651 | 136,305 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 27,744 | 27,451 | 37,525 | 38,354 | 39,519 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 35,999 | 35,039 | 42,540 | 39,990 | 41,254 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 64,262 | 72,795 | 78,734 | 86,661 | 95,051 |
Total Liabilities & Shareholders' Equity | 100,261 | 107,834 | 121,274 | 126,651 | 136,305 |
Total Common Shares Outstanding |